HCW Biologics Profit Margin

HCW Biologics (HCWB) currently reports a profit margin of -437.65% as of June 2026. That compares with -2588.0% in the prior-year period — up 83.1% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore HCW Biologics's profit margin history and peer comparisons.

HCW Biologics's profit margin increased from -2588.0% to -437.65% — a 83.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

HCW Biologics's profit margin of -437.65% is lower than the Healthcare sector average of 14.34%. That is roughly 3150.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but HCW Biologics's current -437.65% should be judged against Healthcare norms (sector average: 14.34%) and against HCWB's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -437.65%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for HCW Biologics, and consider following HCWB for alerts when major investors trade the stock.